Skip to search formSkip to main contentSkip to account menu

KCD 232

Known as: KCD-232 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

4-(4'-chlorobenzyloxy)benzyl nicotinate

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
CEPHALOMETRIC GENDER DIFFERENCE IN THE YOUTH OF KHYBER PAKHTUNKHWA
The objective of this study was to determine the gender difference in the craniofacial relationship of skeletal, dental and soft… 
2011
2011
Rubber and Soul : Moral Economy, Development and Resistance in the Bousraa villages, Mondulkiri, Cambodia
This thesis deals with the establishemnt of the rubber plantation Varanasi in the Bousraa village complex, Mondulkiri Province… 
2002
2002
Identifying collusions : Co-operating malicious hosts in mobile agent itineraries
" # $&% '( ) $ * + ! &, $ ! /."01 2 34 !* # ) 5 # $ %6 7 !* 89 ! " 3: !* ; < 9 <$/ # ! ; '1 !* = /.?>:* ? @8A 5 # ! $ ! B'7 ! C… 
1987
1987
Effects of some hypolipidemic agents on biochemical values and hepatic peroxisomal enzymes in rats: comparison of probucol, CGA, KCD-232, MLM-160, AL-369 and clinofibrate with clofibrate.
The effect of some hypolipidemic agents, which are commercially available and those being developed, on certain biochemical… 
1985
1985
Effect of KCD-232, a new hypolipidemic agent, on serum lipoprotein changes in hepatoma-bearing rats
Changes in serum lipoprotein profiles were characterized in Donryu rats subcutaneously implanted with an ascites hepatoma line of… 
1985
1985
Effect of 4-(4'-chlorobenzyloxy)benzyl nicotinate (KCD-232) on cholesterol metabolism in rats.
1985
1985
Different effects of 4-(4'-chlorobenzyloxy)benzoic acid (MII) on lipid synthesis and cell growth in human and mouse skin fibroblasts.
The effect of 4-(4'-chlorobenzyloxy)benzoic acid (MII), a metabolite of a new hypolipidemic agent 4-(4'-chlorobenzyloxy)benzyl… 
1985
1985
[Experimental nephrotic hyperlipidemia induced in rats by daunorubicin and effects of KCD-232[4-(4'-chlorobenzyloxy)benzyl nicotinate] on lipid metabolism].
Mechanisms for hypercholesterolemia and hypertriglyceridemia and the effects of KCD-232, a new hypolipidemic agent, on them were… 
1984
1984
[Effects of 4-(4'-chlorobenzyloxy) benzyl nicotinate (KCD-232) on lipid metabolism in rats and mice].
The hypolipidemic properties of KCD-232[4-(4'-chlorobenzyloxy) benzyl nicotinate], a new compound, were studied in rats fed a… 
1984
1984
Effect of KCD-232, a New Hypolipidemic Compound, on Hyperlipidemia in Experimental Nephrotic Syndrome Rats
Nephrotic syndrome is characterized by renal damage, protein urina, hypoproteinemia and edema with marked hypercholesterolemia… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)